Lasa Supergenerics's ROE % for the quarter that ended in Mar. 2026 was -33.57%. Lasa Supergenerics's PB Ratio for the quarter that ended in Mar. 2026 was 0.57.
Lasa Supergenerics's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -58.89%.
Lasa Supergenerics ROE % Adjusted to Book Value Related Terms
Lasa Supergenerics ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Lasa Supergenerics's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lasa Supergenerics ROE % Adjusted to Book Value Chart
NSE:LASA vs ZTS, UTHR: ROE % Adjusted to Book Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Lasa Supergenerics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lasa Supergenerics ROE % Adjusted to Book Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Lasa Supergenerics's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Lasa Supergenerics's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of -58.89% mean?
Lasa Supergenerics (NSE:LASA) has a ROE % Adjusted to Book Value of -58.89% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Lasa Supergenerics and its competitors.
Is Lasa Supergenerics' ROE % Adjusted to Book Value too high?
Lasa Supergenerics' current ROE % Adjusted to Book Value is -58.89%. Overall, Lasa Supergenerics has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lasa Supergenerics' ROE % Adjusted to Book Value compare to ZTS and UTHR?
Lasa Supergenerics' ROE % Adjusted to Book Value of -58.89% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Lasa Supergenerics and its competitors. Lasa Supergenerics's current ROE % Adjusted to Book Value is -58.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lasa Supergenerics stock overvalued right now?
Based on GuruFocus' analysis, Lasa Supergenerics (NSE:LASA) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹4.34, compared to a current price of ₹7.43 — trading 71.2% above its estimated fair value. The current ROE % Adjusted to Book Value is -58.89%. Lasa Supergenerics' overall GF Score™ is 38/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Lasa Supergenerics (NSE:LASA), the current ROE % Adjusted to Book Value is -58.89% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lasa Supergenerics (NSE:LASA) Overvalued in 2026?
Based on GuruFocus' analysis, Lasa Supergenerics stock appears to be overvalued.
The current stock price of ₹7.43 is trading 71.2% above its estimated GF Value™ of ₹4.34.
GuruFocus considers Lasa Supergenerics to be Significantly Overvalued.
Key valuation signals for NSE:LASA:
ROE % Adjusted to Book Value: -58.89%
GF Value™: ₹4.34 vs. price of ₹7.43 (71.2% above fair value)
No single metric tells the full story. See the NSE:LASA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lasa Supergenerics Ltd is engaged in the research, manufacturing, trading, producing, processing, preparing, and treating chemicals, API, pharmaceuticals, drugs, and related products. The company specializes in catalyst chemistry and manufactures anthelmintic and veterinary API products. Its product range includes API products, other API products, animal feed ingredients, and reagents for therapeutic use.
38GF Score
Get the complete analysis for NSE:LASA
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:LASA has been successfully added to your 
